Paul Scigalla
Technik-/Wissenschafts-/F&E-Leiter bei GENELUX CORPORATION
Aktive Positionen von Paul Scigalla
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENELUX CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2011 | - |
| Ruprecht-Karls-Universität Heidelberg | Corporate Officer/Principal | 01.01.1992 | - |
Karriereverlauf von Paul Scigalla
Ehemalige bekannte Positionen von Paul Scigalla
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY. | Corporate Officer/Principal | 01.01.1998 | 01.01.2001 |
| NUEVOLUTION AB (PUBL) | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 | - |
| DEUTSCHE BIOTECH INNOVATIV AG | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Paul Scigalla
| Humboldt-Universität zu Berlin | Doctorate Degree |
Statistik
International
| Deutschland | 4 |
| Vereinigte Staaten | 3 |
| Dänemark | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Finance |
| GENELUX CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Paul Scigalla
- Erfahrung
